FINWIRES · TerminalLIVE
FINWIRES

Volta Metals公司获得安大略省初级勘探计划21.5万美元拨款

By

-- Volta Metals (VLTA.CN) 周一宣布，公司已获得安大略省初级勘探计划 (OJEP) 的最高 21.5 万美元资助。 该公司表示，这笔资金将用于其位于安大略省萨德伯里以东约 70 公里处、占地 4,750 公顷的 Springer 稀土元素 (REE) 和镓项目在 2025 年及 2026 年前两个月的合格勘探支出。 该公司指出，此次获得的 21.5 万美元是 OJEP 每个项目可获得的最高资助金额，最高可覆盖 2025 年及 2026 年初野外勘探季在安大略省发生的合格矿产勘探支出的 50%。该公司补充说，这笔资金使 Volta 能够扩大其在 Springer 稀土矿床的勘探计划，并推进针对稀土和镓矿化的钻探和地球物理勘探项目。 “安大略省政府的这项拨款是对斯普林格稀土项目以及我们团队过去一年所取得的显著进展的有力认可，”首席执行官凯雷姆·乌森梅兹 (Kerem Usenmez) 表示。“安大略省勘探开发计划 (OJEP) 的资助有助于降低勘探风险，使我们能够在现阶段推进更积极的油田勘探计划，而无需进一步稀释股东权益。” 该公司股票在加拿大证券交易所的最新报收于 0.185 加元，下跌 0.005 加元。

Price: $0.19, Change: $-0.01, Percent Change: -2.63%

Related Articles

Insider Trading

Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing

Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml

$LFST
Australia

Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.

$CLS
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.

$AMP